Introduction
The Haptoglobin (Hp) Typing ELISA is intended for use for diabetic patients only, for the qualitative determination of Hp phenotypes (Hp 1-1, Hp 2-1, or Hp 2-2) in human serum/plasma.
The public health burden of cardiovascular and renal complications from Diabetes Mellitus (DM) is over $100 billion per year in the USA alone and the problem is increasing. Medications to treat these complications are extremely expensive and require lifetime use. The purpose of this diagnostic test is to provide a once in a lifetime test that will indicate whether a particular DM individual is at high risk for these diabetic complications and may benefit from Vitamin E supplementation. Savyon Diagnostics is offering a novel ELISA kit intended for rapid and simple Haptoglobin (Hp) Typing. This test will give the patient and the physician information as to which of the three Hp types the patient has – Hp 1-1, Hp 2-1 or Hp 2-2
Features
- The only available Immunoassay for high-throughput Haptoglobin phenotyping
- A highly valuable tool for prognosis of CVD risk in diabetic patients and as a pharmacogenetic tool to assess the benefit of high dose vitamin E in such patients
- Manual and automated protocols
- Ready to use reagents
- Serum/Plasma sample
Cat# 710-01
